• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov11
Matinas Biopharma released FY2025 9 Months Earnings on November 10, 2025 (EST) with actual revenue of USD 0 and EPS of USD -1.3565
04:00
Matinas Biopharma released FY2025 Q3 earnings on November 10 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.3955 (forecast USD --)
04:00
Aug15
Matinas Biopharma released FY2025 Semi-Annual earnings on August 14, 2025 (EST) with actual revenue of USD 0 and EPS of USD -1.3565
03:00
Matinas Biopharma released FY2025 Q2 earnings on August 14, 2025 (EST), with actual revenue of USD 0 and EPS of USD -1.031
03:00
May16
Matinas Biopharma released FY2025 Q1 earnings on May 15, 2025 (EST) with actual revenue of USD 0 and EPS of USD -0.3255
03:00
May2
Matinas Biopharma Holdings Amends Key Executives' Employment Contracts
21:16

Schedules & Filings

Schedules
Filings
Nov10
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -2.15 M, EPS -0.3955

Aug14
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -5.245 M, EPS -1.031

May15
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -1.656 M, EPS -0.3255

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
PCSA
5.800
+93.01%
+2.875
ATPC
0.1480
+64.44%
+0.059
YCBD
2.274
+59.02%
+0.849
VYNE
0.6165
+53.09%
+0.214
ISPO
4.175
+47.01%
+1.335
MGRT
7.560
+41.31%
+2.210
ANDG
21.000
+31.25%
+5.000
GVH
3.785
+28.31%
+0.880
TGL
7.689
+25.02%
+1.510
DDL
2.814
+23.44%
+0.534
View More